Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2020
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission
Gordon Glober, Jillian Gunther, Penny Fang, et al.
Haematologica
|
November 17, 2022
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response
Andrew P Jallouk, Sushanth Gouni, Jason Westin, et al.
British Journal of Haematology
|
October 12, 2023
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function
Omar Mamlouk, Paolo Strati, Lei Feng, et al.
Head & Neck
|
April 17, 2019
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
Alison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma
Chelsea C Pinnix, Grace L Smith, Sarah Milgrom, et al.
The Lancet. Oncology
|
December 8, 2015
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Michael L Wang, Hun Lee, Hubert Chuang, et al.
Blood Advances
|
May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
British Journal of Haematology
|
September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant
Hua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
Blood Cancer Journal
|
July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma
Karan L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2020
Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission
Gordon Glober, Jillian Gunther, Penny Fang, et al.
Haematologica
|
November 17, 2022
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response
Andrew P Jallouk, Sushanth Gouni, Jason Westin, et al.
British Journal of Haematology
|
October 12, 2023
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function
Omar Mamlouk, Paolo Strati, Lei Feng, et al.
Head & Neck
|
April 17, 2019
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma
Chelsea C Pinnix, Bouthaina S Dabaja, Sarah A Milgrom, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
Alison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma
Chelsea C Pinnix, Grace L Smith, Sarah Milgrom, et al.
The Lancet. Oncology
|
December 8, 2015
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Michael L Wang, Hun Lee, Hubert Chuang, et al.
Blood Advances
|
May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
British Journal of Haematology
|
September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant
Hua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
Blood Cancer Journal
|
July 2, 2026
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma
Karan L Chohan, Eduardo Edelman Saul, R Eric Davis, et al.
Page
of 10